These supplements may function as glycation scavengers to neutralize MGO and act as pharmacological chaperones, potentially reversing TPI deficiency in humans and aiding in the prevention and treatment of chronic and degenerative diseases. This evidence concerns the gene TPI1 and neurodegenerative disease.